(4S,4'S)-2,2'-(Pentane-3,3-diyl)bis(4-isopropyl-4,5-dihydrooxazole), 97%, 1g

3-ethenyl-4-fluoropyridin-2-ol, 97.0%, 500mg

4'-chloro-3-(2,6-dimethylphenyl)-2'-fluoropropiophenone, 97.0%, 1g

Acide 5,5'-dithio-bis-(-2-nitrobenzoïque), min 98 %, pa, 5 g, emballage en verre

2-(3,5-Dimethyl-phenoxy)-1-methyl-ethylamine, 95.0%, 250mg

TERT-BUTYL (7-BROMOHEPTYL)CARBAMATE, 95.0%, 10g

N-Methyl-4-quinazolinamine, 1g

5-Nitro-2-(trifluoromethyl)benzonitrile, 95.0%, 5g

5-Bromo-N1-isopropylbenzene-1,2-diamine, 95+%, 5g

5-Pyrimidinecarboxamide, N-hydroxy-2-[(1-phenylcyclopropyl)amino]-, 5mg

2,4-dimethoxy-5-methylbenzoic acid, 95.0%, 250mg

3-Fluoro-6,7-dihydrocyclopenta[b]pyridin-5-one, 98%, 250mg

8-Methylquinoline>99.0%(GC)25g